Search

cobas® s 201 system

The first multi-dye NAT screening system

IVD For in vitro diagnostic use.
cobas s 201 system

cobas s 201 system

The cobas s 201 system is a complete NAT solution supporting the central needs of blood screening labs, combining the efficiency and reliability of real-time PCR technology with modular automation, ready-to-use reagents and a robust menu selection.

cobas s 201 system
Do you have any questions?
Contact us
Protect patients from infectious diseases with modular NAT screening

The cobas s 201 system is a complete nucleic acid testing (NAT) solution that supports the central needs of blood screening laboratories with assays covering HIV, HCV, HBV, HAV, parvovirus B19 and West Nile virus.

Combining real-time PCR technology and modular automation, the cobas s 201 system minimizes hands-on time across the entire testing process, while multi-dye technology makes confirmatory testing obsolete.

A modular design that allows expansion with ready to use reagents, integrated back-up capabilities, and built-in contamination control to meet increased testing demands.

High scalability and impressive flexibility
  • Streamlines lab workflow
  • Real-time PCR allows amplification and detection of RNA and DNA within hours
  • Supports simultaneous multiple assay processing
  • Accommodates integrated backup to maximize lab productivity
  • Flexible, mix-and-match scalability helps NAT labs work more efficiently
Powerful pooling and data management (PDM) software
  • Provides built-in redundancy, full system audit and data security
  • Supports various pool sizes or individual donation testing
  • Supports simultaneous pool creation to handle multiple assays
  • Provides multiple search and reporting options
Easy sample preparation, large load capacity
  • Automates every step of the RT-PCR-based blood screening process
  • Includes automated pooling using the Hamilton MICROLAB® STAR IVD Pipettor
Result integrity
  • Closed-tube format requires no user interaction after sample loading is completed
  • Reduces the risk of sample contamination
  • Software-guided workflow
  • Sample and reagent ID tracked throughout process
Advanced diagnostic technology for donor screening

The cobas s 201 system uniquely addresses the challenges facing your lab in ensuring a safer blood supply. It affords flexibility and scalability, boosts operational efficiency and ensures result integrity.

Registration status

IVD

Related portfolios

Explore Roche's donor screening solutions

...
    ...
    Contact us

    Overview

    Ordering Information

    Back     Next
    cobas® SARS-CoV-2 test kit
    cobas® SARS-CoV-2 Test
    Country Specific Labeling See country-specific product labeling for regulatory status.
    Product image for LightCycler® 96 System
    LightCycler® 96 Instrument Obtain fast, highly sensitive, and reproducible results for qualitative and quantitative detection of nucleic acids and SNP analysis with the LightCycler® 96.
    Country Specific Labeling See country-specific product labeling for regulatory status.
    Product image for LightCycler® 2.0 System
    LightCycler® 2.0 Instrument Monitor amplification of 32 PCR products simultaneously and obtain fast, highly reproducible results with the LightCycler® 2.0 System.
    IVD For in vitro diagnostic use.
    Product image for MagNA Pure 24 System
    MagNA Pure 24 Instrument A fully-automated clinical nucleic acid extraction system that brings you walkaway automation for up to 24 samples. Designed around the real needs of modern laboratories. Prepare up to 24 samples in just over an hour, or run the fast protocol for up to 8 samples in 30 minutes or less. Flexibility starts here.
    IVD For in vitro diagnostic use.
    Product image for MagNA Pure 96 System
    MagNA Pure 96 Instrument High-throughput robotic workstation for fully automated purification of nucleic acids from up to 96 samples. Take your lab to new levels of efficiency. Purify DNA and RNA from a wide range of starting materials using magnetic glass particle technology on the MagNA Pure 96 System.
    IVD For in vitro diagnostic use.
    cobas prime pre-analytical system
    cobas® prime Pre-analytical System The industry’s leading instruments converge to form a single solution that transforms your operation into a laboratory of the future. This fully automated system consolidates, integrates and standardizes the pre-analytical process to streamline lab operations.
    LSR For life science research only. Not for use in diagnostic procedures.
    cobas omni Optimization Kit
    cobas omni Optimization Kit cobas omni Optimization Kit - Rapid optimization of LDTs for consolidation on the cobas omni Utility Channel - For Research Use Only. Not for use in diagnostic procedures.
    GLU For general laboratory use.
    FLOW Solution
    FLOW Solution Go with the FLOW Solution from Roche, for complete workflow standardization and data automation throughout testing.
    IVD For in vitro diagnostic use.
    digital lightcycler product thumbnail
    Digital LightCycler® System Unleash the true power of digital PCR
    IVD For in vitro diagnostic use.
    UC-TIB-AdV
    UC-TIB-AdV Real time PCR kit for quantification of human Adenovirus.
    For use with the cobas® omni utility channel on the cobas® 6800/8800 Systems.     Real time PCR kit for quantification of human Adenovirus. For use with the cobas® omni utility channel on the cobas® 6800/8800 Systems.
    IVD For in vitro diagnostic use.
    UC-TIB-HSV/VZV
    UC-TIB-HSV/VZV Real time PCR kit for qualitative detection of human Herpes Simplex Virus 1/2 and Varicella Zoster Virus.
    For use with the cobas® omni utility channel on the cobas® 6800/8800 Systems.     Real time PCR kit for qualitative detection of human Herpes Simplex Virus 1/2 and Varicella Zoster Virus. For use with the cobas® omni utility channel on the cobas® 6800/8800 Systems.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> Influenza A/B &amp; RSV
    cobas® Influenza A/B & RSV Nucleic acid test for use on the cobas® liat system Diagnose and differentiate influenza A/B & RSV for effective clinical management and infection control with the POC multiplex PCR test for use on the cobas® liat system.
    IVD For in vitro diagnostic use.
    Product Image for cobas® 4800 system
    cobas® 4800 system Discover real-time PCR amplification and detection featuring fully automated sample preparation, high quality nucleic acid extraction and robust engineering.
    IVD For in vitro diagnostic use.
    cobas® liat system
    cobas® liat system Bring accurate and reliable PCR results to the POC, enabling answers patients and clinicians need in 20 minutes or less to support triage and patient management.
    IVD For in vitro diagnostic use.
    cobas omni Utility Channel
    cobas omni Utility Channel For use on the cobas® 5800/6800/8800 Systems Consolidate and automate IVD and LDTs on one platform with the cobas omni Utility Channel—maximise laboratory space, minimise capital investment, and decrease operational costs.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> SARS-CoV-2 &amp; Influenza A/B
    cobas® SARS-CoV-2 & Influenza A/B Nucleic acid test for use on the cobas® liat system Detect and differentiate SARS-CoV-2, influenza A and influenza B in 20 minutes from a single sample and in just one RT-PCR test for use on the cobas® liat system.
    <b>cobas</b><sup>®</sup> SARS-CoV-2
    cobas® SARS-CoV-2 Nucleic acid test for use on the cobas® liat system Inform decisions at the POC with targeted RT-PCR SARS-CoV-2 test results in 20 minutes for both asymptomatic and symptomatic individuals using the cobas® liat system.
    IVD For in vitro diagnostic use.
    cobas p 480 instrument
    cobas p 480 Instrument Improve workflow, reduce the risk of contamination, and make the most of your technician’s time. For support of cobas® 4800/6800/8800 Systems.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> Strep A
    cobas® Strep A Nucleic acid test for use on the cobas® liat system With lab-quality results in ~15 minutes, cobas® Strep A, for use on the cobas® liat system aids clinicians to make immediate, informed treatment decisions.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> Cdiff
    cobas® Cdiff Nucleic acid test for use on the cobas® liat system Provide accurate, on-demand results in 20 minutes for the detection of toxigenic C. diff with the POC PCR test for use on the cobas® liat system.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> SARS-CoV-2 &amp; Influenza A/B v2
    cobas® SARS-CoV-2 & Influenza A/B v2 Qualitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems cobas® SARS-CoV-2 & Influenza A/B v2 assay for use on the cobas® 5800/6800/8800 Systems (cobas® SARS-CoV-2 & Influenza A/B v2) is an automated multiplex real-time RT-PCR assay intended for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab specimens, and self-collected nasal swab specimens (collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. cobas® SARS-CoV-2 & Influenza A/B v2 is intended for use as an aid in the differential diagnosis of SARS-CoV-2, influenza A, and influenza B in humans and is not intended to detect influenza C.RNA from SARS-CoV-2, influenza A, and influenza B is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2, influenza A, and/or influenza B RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.Negative results do not preclude infection from SARS-CoV-2, influenza A, and/or influenza B and should not be used as the sole basis for treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.cobas® SARS-CoV-2 & Influenza A/B v2 is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and on the use of the cobas® 5800/6800/8800 Systems.
    IVD For in vitro diagnostic use.
    cobas® 5800 System
    cobas® 5800 System The cobas® 5800 System makes automation, consolidation, integration and standardization more accessible than ever before.
    IVD For in vitro diagnostic use.
    cobas® 6800 System
    cobas® 6800 System Embrace the future of molecular testing with proven PCR performance. Learn about the cobas® 6800 System’s broad menu of high-quality assays, including HIV, HPV, CT/NG, Hepatitis, CMV, WNV, respiratory infections, and more!
    IVD For in vitro diagnostic use.
    cobas® 8800 System
    cobas® 8800 System Run up to 1,056 tests in an 8-hour shift and experience unparalleled automation - only 3 user interactions per run for up to 4 hours of walk-away time.
    IVD For in vitro diagnostic use.
    GenMark ePlex System
    ePlex® system The only sample-to-answer solution on the market that streamlines the diagnostic workflow from your order entry to final report.
    Country Specific Labeling See country-specific product labeling for regulatory status.
    cobas z 480 analyzer
    cobas z 480 analyzer The cobas z 480 analyzer is a component of the modular cobas® 4800 System, and can also exist as a standalone instrument for automated amplification and detection of clinical and research assays. The cobas z 480 analyzer offers advanced real-time PCR technology for high-quality results.
    RUO For Research Use Only. Not for use in diagnostic procedures.
    <b>cobas</b><sup>®</sup> SARS-CoV-2 Duo
    cobas® SARS-CoV-2 Duo Qualitative and quantitative assay for use on the cobas® 5800/6800/8800 Systems Proposed UseThe cobas® SARS-CoV-2 Duo for use on the cobas® 6800/8800 Systems (cobas® SARS-CoV-2 Duo) is an automated real-time RT-PCR assay for the in vitro qualitative and quantitative detection of SARS-CoV-2 RNA in nasal and nasopharyngeal swab specimens.cobas® SARS-CoV-2 Duo is intended for research use only and is not for use in diagnostic procedures.
    LSR For life science research only. Not for use in diagnostic procedures.
    LightCycler® 480 System
    LightCycler® 480 Instrument II Obtain fast, highly sensitive, and reproducible results with the LightCycler® 480 System. Amplify your success in medium and high-throughput real-time PCR.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> WNV Test
    cobas® WNV Test Nucleic acid test for use on the cobas® 6800/8800 Systems
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> WNV Test
    cobas® WNV Test Nucleic acid test for use on the cobas® 5800/6800/8800 Systems
    IVD For in vitro diagnostic use.
    LightCycler® PRO System
    LightCycler® PRO System LightCycler® PRO integrates innovative technology and Roche manufacturing to deliver accurate real-time PCR results
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> SARS-CoV-2 &amp; Influenza A/B
    cobas® SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems cobas® SARS-CoV-2 & Influenza A/B assay for use on the cobas® 5800/6800/8800 Systems (cobas® SARS-CoV-2 & Influenza A/B) is an automated multiplex real-time RT-PCR assay intended for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab specimens, and self-collected nasal swab specimens (collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID‑19 by their healthcare provider. cobas® SARS-CoV-2 & Influenza A/B is intended for use as an aid in the differential diagnosis of SARS-CoV-2, influenza A, and influenza B in humans and is not intended to detect influenza C.RNA from SARS-CoV-2, influenza A, and influenza B is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2, influenza A, and/or influenza B RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.Negative results do not preclude infection from SARS-CoV-2, influenza A, and/or influenza B and should not be used as the sole basis for treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.cobas® SARS-CoV-2 & Influenza A/B is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and on the use of the cobas® 5800/6800/8800 Systems.
    IVD For in vitro diagnostic use.
    symbol for cobas synergy software
    cobas® Synergy Software For use with cobas® 6800/8800 Systems (software version 1.2.13) and Microlab® STAR IVD High capacity pooling and archiving of blood donations
    Parainfluenza
    cobas® Paraflu 1-4 UC Test
    cobas® 4800 BRAD V600 Mutation Test
    cobas® 4800 BRAF V600 Mutation Test
    Product image for COBAS® EBV
    cobas® EBV
    GenMark ePlex RP2 panel
    ePlex® Respiratory Pathogen Panel 2
    GenMark ePlex BCID panels
    ePlex® Blood Culture Identification Panels
    Product image for cobas® HCV Test
    cobas® HCV Test
    error errorMessage
    Sorry, we couldn't find the content you are looking for
    Please try again later